Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025
(NASDAQ:DAWN), BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced it will host a live conference call and webcast on Tuesday, November 4, 2025 at 4:30 […]